STOCK TITAN
  1. Home
  2. News
  3. CVII

Churchill Capital Corp VII - $CVII STOCK NEWS

Welcome to our dedicated page for Churchill Capital VII news (Ticker: $CVII), a resource for investors and traders seeking the latest updates and insights on Churchill Capital VII stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Churchill Capital VII's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Churchill Capital VII's position in the market.

News
Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024
Rhea-AI Summary
Churchill Capital Corp VII (CVII) announces a special meeting for stockholders and warrant holders to vote on the proposed business combination with CorpAcq Holdings The Business Combination is expected to be completed in the first half of 2024, creating a publicly-traded corporate compounder with a strong portfolio of 42 businesses. CorpAcq Group Plc plans to implement an annual dividend policy supported by strong free cash flow. The Board recommends voting 'FOR' all proposals in the Proxy Statement for both stockholders and warrant holders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
none
-
News
Churchill Capital Corp VII Announces Stockholder Approval of Extension and Final Redemption Numbers
Rhea-AI Summary
Churchill Capital Corp VII announces stockholder approval to extend Business Combination date with CorpAcq Holdings Limited. Over $605 million remains in trust account post-redemptions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
none
-
News
Churchill Capital Corp VII Announces Continuation of $1,000,000 Monthly Sponsor Contribution
Rhea-AI Summary
Churchill Capital Corp VII is holding a special meeting of stockholders on February 8, 2024, to vote on extending the date by which it must consummate its business combination with CorpAcq Holdings Limited. The purpose of the extension is to allow additional time to complete the transactions. Churchill VII's sponsor will continue to make monthly contributions to the trust account, and the company plans to transfer its listing to the Nasdaq Global Market from the New York Stock Exchange.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
none
News
Churchill Capital Corp VII Announces Intention to Transfer Listing to Nasdaq
Rhea-AI Summary
Churchill Capital Corp VII (CVII) plans to transfer its listing from NYSE to Nasdaq, expecting to commence trading on Nasdaq on February 5, 2024. The company also announced a definitive agreement for a business combination with CorpAcq Holdings Limited, subject to closing conditions and approval by stockholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
none
-
News
CorpAcq Reaffirms 2023 Guidance and Provides Business and Refinancing Update
Rhea-AI Summary
CorpAcq Holdings Limited provides a business update, reaffirming guidance for the full year ending December 31, 2023, confirming the timing of its Business Combination with Churchill Capital Corp VII, announcing a successful refinancing of its group debt, and an upcoming Analyst Day. The company reaffirms its 2023 revenue and Adjusted EBITDA guidance, with expected revenue of approximately £729 million and Adjusted EBITDA of approximately £126 million. The Business Combination with Churchill VII remains on track, with a special meeting of stockholders to be held on February 8, 2024. CorpAcq has successfully refinanced its group debt facility, providing more financial flexibility and liquidity. An upcoming Analyst Day is scheduled for January 25, 2024, in preparation for a public listing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
none
-
News
CorpAcq and Churchill Capital Corp VII Announce Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination and CorpAcq's First Half 2023 Results
Rhea-AI Summary
Churchill Capital Corp VII (CVII) and CorpAcq Holdings Limited announced the filing of a registration statement of CorpAcq Group on Form F-4 with the SEC. The Registration Statement contains a proxy statement/prospectus in connection with the proposed business combination, subject to change.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
earnings
News
CorpAcq to Go Public via Business Combination with Churchill Capital Corp VII
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
none
Stock CVII logo
Churchill Capital Corp VII

Nasdaq:CVII

CVII Rankings

#2449 Ranked by Market Cap
#1688 Ranked by Stock Gains
N/A Ranked by Dividends

CVII Stock Data

982.03M
2.44M
100.81%
0.01%
Shell Companies
Financial Services
Link
United States of America
NEW YORK